Loading provider…
Loading provider…
Medical Oncology Physician in Chicago, IL
NPI: 1437187929Primary Practice Location
NORTHWESTERN LAKE FOREST HOSPITAL
1000 N Westmoreland Rd, Lake Forest, IL
Primary Employer
Northwestern Medical Group
nm.org
HQ Phone
Get MD William's Phone Numberphone_androidMobile
Get MD William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 341 | 612 |
| 2 | 96413Infusion of chemotherapy into a vein up to 1 hour | 67 | 304 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 58 | 168 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 52 | 52 |
| 5 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 47 | 311 |
Authors: Zaraq Khan, Christos Coutifaris, Lilibeth Torno, Steven Lindheim, Divya Shah, Jodi Skiles, Leena Nahata, Jennifer Mersereau, Lillian Meacham, Jill Ginsberg, Molly Moravek, Pooja Rao, Courtney Finlayson, Wendy Vitek, Veronica Gomez-Lobo, Courtney Marsh, Leonard Sender, William Kutteh, Danny Schust, Jennifer Hirshfeld-Cytron
Journal: Future Oncol
Publication Date: 2018-11-26
Authors: Lidia Schapira, Claudia Perez, Elaine Yu, Alyssa Throckmorton, Swati Kulkarni, Kent Hoskins, Editha Krueger, Della Makower, Shelly Lo
Journal: JCO Oncol Pract
Adjuvant endocrine therapy for early breast cancer: the story so far.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Cancer Invest
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Placebo, DRUG: Fulvestrant, DRUG: GSK525762
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Trastuzumab, DRUG: Pertuzumab, DRUG: Alpelisib, DRUG: Alpelisib matching Placebo
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, PROCEDURE: Biopsy, PROCEDURE: Bone Scan, BIOLOGICAL: Pertuzumab